This Article Free upon publication Full Text Full Text (PDF) CME: Take the course for this article: Circulation: August 26, 2008, Volume 118, Number 9 All Versions of this Article: 118/9/926    most recent CIRCULATIONAHA.108.773838v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Piccini, J. P. Search for Related Content PubMed PubMed Citation Articles by Piccini, J. P. Related Collections Congestive Pacemaker Related Article

(Circulation. 2008;118:926-933.)
© 2008 American Heart Association, Inc.

Heart Failure

Use of Cardiac Resynchronization Therapy in Patients Hospitalized With Heart Failure

Jonathan P. Piccini, MD; Adrian F. Hernandez, MD, MHS; David Dai, PhD, MS; Kevin L. Thomas, MD; William R. Lewis, MD; Clyde W. Yancy, MD; Eric D. Peterson, MD, MPH; Gregg C. Fonarow, MD, for the Get With the Guidelines Steering Committee and Hospitals

From the Duke Clinical Research Institute, Durham, NC (J.P.P., A.F.H., D.D., K.L.T., E.D.P.); MetroHealth Medical Center, Cleveland, Ohio (W.R.L.); Baylor Heart and Vascular Institute, Dallas, Tex (C.W.Y.); and University of California Los Angeles Medical Center, Los Angeles (G.C.F.).

Correspondence to Adrian F. Hernandez, MD, MHS, Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715. E-mail adrian.hernandez{at}duke.edu

Received February 15, 2008; accepted June 20, 2008.

Background— The frequency and characterization of patients receiving cardiac resynchronization therapy (CRT) are largely unknown since the publication of pivotal clinical trials and subsequent incorporation of CRT into the American College of Cardiology/American Heart Association guidelines for heart failure.

Methods and Results— We analyzed 33 898 patients admitted from January 2005 through September 2007 to 228 hospitals participating in the American Heart Association’s Get With the Guidelines–Heart Failure program. There were 4201 patients (12.4%) discharged alive with CRT, including 811 new implants. Patients discharged with CRT were older (median age, 75 versus 72 years) and had lower median left ventricular ejection fraction (30% versus 38%), more frequent ischemic cardiomyopathy (58% versus 45%), more history of atrial fibrillation (38% versus 27%), and higher rates of β-blocker and aldosterone antagonist use (P<0.0001 for all) than those without CRT. We found that 4.8% of patients with left ventricular ejection fraction 35% were discharged with a new CRT implant, which varied greatly by hospital. Ten percent of patients discharged with a new CRT implant had a left ventricular ejection fraction >35%. Major factors associated with lower rates of new CRT placement were treatment in the northeast (odds ratio, 0.40; 95% confidence interval, 0.30 to 0.53), black race (odds ratio, 0.45; 95% confidence interval, 0.36 to 0.57), increasing left ventricular ejection fraction per 10% (odds ratio, 0.56; 95% confidence interval, 0.52 to 0.60), and increasing age per 10 years in those >70 years of age (odds ratio, 0.56; 95% confidence interval, 0.48 to 0.65).

Conclusions— Although CRT is a recent evidence-based therapy for heart failure, patterns of use differ significantly from clinical trials and published guidelines. Important variations also exist for CRT therapy based on race, geographic region, comorbidities, and age and need to be addressed through further study and/or quality-of-care initiatives.

---

 

CLINICAL PERSPECTIVE

Related Article:

Clinical Summaries
Circulation 2008 118: 897-898. [Extract] [Full Text]

This article has been cited by other articles:

				M. A. Hlatky and P. Heidenreich The Year in Epidemiology, Health Services Research, and Outcomes Research J. Am. Coll. Cardiol., December 15, 2009; 54(25): 2343 - 2351. [Full Text] [PDF]

				D. J. van Veldhuisen, A. H. Maass, S. G. Priori, P. Stolt, I. C. van Gelder, K. Dickstein, and K. Swedberg Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008 Eur J Heart Fail, December 1, 2009; 11(12): 1143 - 1151. [Abstract] [Full Text] [PDF]

				M. Gasparini, C. Menozzi, A. Proclemer, M. Landolina, S. Iacopino, A. Carboni, E. Lombardo, F. Regoli, M. Biffi, V. Burrone, et al. A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD] study Eur. Heart J., November 2, 2009; 30(22): 2758 - 2767. [Abstract] [Full Text] [PDF]

				K. Dickstein, N. Bogale, S. Priori, A. Auricchio, J. G. Cleland, A. Gitt, T. Limbourg, C. Linde, D. J. van Veldhuisen, J. Brugada, et al. The European cardiac resynchronization therapy survey Eur. Heart J., October 2, 2009; 30(20): 2450 - 2460. [Abstract] [Full Text] [PDF]

				J. P. Piccini, A. F. Hernandez, X. Zhao, M. R. Patel, W. R. Lewis, E. D. Peterson, G. C. Fonarow, and Get With The Guidelines Steering Committee and Hos Quality of care for atrial fibrillation among patients hospitalized for heart failure. J. Am. Coll. Cardiol., September 29, 2009; 54(14): 1280 - 1289. [Abstract] [Full Text] [PDF]

				The CRT Survey Scientific Committee European cardiac resynchronization therapy survey: rationale and design Eur J Heart Fail, March 1, 2009; 11(3): 326 - 330. [Abstract] [Full Text] [PDF]

				C. W. Yancy and G. Filardo Cardiac Resynchronization Therapy for Heart Failure: Has the Time Come? Circulation, February 24, 2009; 119(7): 916 - 918. [Full Text] [PDF]

				F. A. McAlister Cardiac Resynchronization Therapy for Heart Failure: A Hammer in Search of Nails Circulation, August 26, 2008; 118(9): 901 - 903. [Full Text] [PDF]